S&P 500 7,418.44 −3.51%
Nasdaq 24,384.46 −5.25%
S&P/TSX 35,693.15 −1.78%
Apple 347.51 −0.57%
Nvidia 182.40 −8.86%
Microsoft 535.40 −3.67%
Shopify 194.90 −8.37%
Royal Bank 287.42 −1.76%
CAD/USD 0.7143 +0.04%
LIVE · 11:05 ET
Market ClerkRecap
Thu Nov 5 · markets open2 signals today194 insider buys this week · $438.8MCIRO short report next: Nov 15The week ahead
PS
INSIDER · XERS · Xeris Biopharma Holdings, Inc. · SEE REMARKS

Pieper Steven

Every open-market transaction filed under this name, Sep 1 to Nov 2.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$141K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 2XERSXeris Biopharma Holdings, Inc.See RemarksSell5,000$10.23$51K—
Oct 1XERSXeris Biopharma Holdings, Inc.See RemarksSell5,000$9.41$47K—
Sep 1XERSXeris Biopharma Holdings, Inc.See RemarksSell5,000$8.50$43K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.